Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus

Explore clinical trials studying Respiratory Syncytial Virus. Study availability and eligibility vary by location and protocol.

40 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus trial results

Completed

A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

NCT06097299

Conditions
Infections, Respiratory Syncytial Virus, Virus Diseases
Locations
  • Velocity Clinical Research, Phoenix Phoenix, Arizona, United States
  • Headlands Research - Scottsdale Scottsdale, Arizona, United States
  • Velocity Clinical Research - Banning Banning, California, United States
  • ASCADA Research, LLC - Family Medicine Fullerton, California, United States
View all 50 locations
View Trial Details
Completed

A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants

NCT06325657

Conditions
Infections, Respiratory Syncytial Virus, Respiratory Tract Diseases, +1 more
Locations
  • Synergy Biomed Research Institute East London, Eastern Cape, South Africa
  • Josha Research Bloemfontein, Free State, South Africa
  • Worthwhile Clinical Trials Benoni, Gauteng, South Africa
  • REIMED Reiger Park Boksburg, Gauteng, South Africa
View all 14 locations
View Trial Details
Completed

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

NCT06143046

Conditions
Infections, Respiratory Syncytial Virus, Virus Diseases
Locations
  • SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS Dothan, Alabama, United States
  • Abby's Research Institute Phoenix, Arizona, United States
  • Watching Over Mothers & Babies Tucson, Arizona, United States
  • Applied Research Center of Arkansas - ClinEdge - PPDS Little Rock, Arkansas, United States
View all 56 locations
View Trial Details
Completed

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

NCT07117487

Conditions
Infections, Respiratory Syncytial Virus, Virus Diseases
Locations
  • Velocity Clinical Research, Denver Denver, Colorado, United States
  • Indago Research & Health Center, Inc. Hialeah, Florida, United States
  • Velocity Clinical Research, Savannah Savannah, Georgia, United States
  • Velocity Clinical Research, Valparaiso Valparaiso, Indiana, United States
View Trial Details
Completed

A Study of Modified mRNA Vaccines in Healthy Adults

NCT05397223

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +18 more
Locations
  • CenExel Hollywood, Florida, United States
  • Meridian Clinical Research Savannah, Georgia, United States
  • Meridian Clinical Research Sioux City, Iowa, United States
  • Johnson County Clinical Trials Lenexa, Kansas, United States
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea

NCT06593587

Conditions
Infections, Respiratory Syncytial Virus, Respiratory Tract Diseases, +1 more
Locations
  • Inha University Hospital Incheon, Incheon-gwangyeoksi [incheon], South Korea
  • Jeonbuk National University Hospital Jeonju, Jeonrabugdo, South Korea
  • Chonnam National University Hospital Gwangju, Kwangju-kwangyǒkshi, South Korea
  • Korea University Ansan Hospital Ansan-si, Kyǒnggi-do, South Korea
View all 16 locations
View Trial Details
Completed

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

NCT05330975

Conditions
Infections, Respiratory Syncytial Virus, Virus Diseases
Locations
  • Central Research Associates Inc Birmingham, Alabama, United States
  • Del Sol Research Management - Clinedge - PPDS Tucson, Arizona, United States
  • Paragon Rx Clinical, Inc Garden Grove, California, United States
  • Ark Clinical Research Long Beach, California, United States
View all 62 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

NCT05127434

Conditions
Infections, Respiratory Syncytial Virus, Virus Diseases
Locations
  • AES - DRS - Synexus Clinical Research US, Inc. - Birmingham Birmingham, Alabama, United States
  • Accel Research Site - Achieve - Birmingham Birmingham, Alabama, United States
  • Lakeview Clinical Research Guntersville, Alabama, United States
  • AES - DRS - Optimal Research Alabama - Huntsville Huntsville, Alabama, United States
View all 269 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

NCT06060457

Conditions
Infections, Respiratory Syncytial Virus, Virus Diseases
Locations
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Headlands Research, Inc. Scottsdale, Arizona, United States
  • West Coast Research LLC Dublin, California, United States
  • Artemis Institute for Clinical Research Riverside, California, United States
View all 34 locations
View Trial Details

Related conditions